SK238692A3 - Use 1,4-dihydropyridines for preparation of medicaments for diabetes treating - Google Patents
Use 1,4-dihydropyridines for preparation of medicaments for diabetes treating Download PDFInfo
- Publication number
- SK238692A3 SK238692A3 SK2386-92A SK238692A SK238692A3 SK 238692 A3 SK238692 A3 SK 238692A3 SK 238692 A SK238692 A SK 238692A SK 238692 A3 SK238692 A3 SK 238692A3
- Authority
- SK
- Slovakia
- Prior art keywords
- nimodipine
- treated
- diabetic
- group
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4125116A DE4125116A1 (de) | 1991-07-30 | 1991-07-30 | Verwendung von 1,4-dihydropyridinen bei diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK238692A3 true SK238692A3 (en) | 1995-11-08 |
Family
ID=6437256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK2386-92A SK238692A3 (en) | 1991-07-30 | 1992-07-30 | Use 1,4-dihydropyridines for preparation of medicaments for diabetes treating |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0525537B1 (hu) |
| JP (1) | JP3381198B2 (hu) |
| KR (1) | KR930001908A (hu) |
| AT (1) | ATE111732T1 (hu) |
| AU (1) | AU659177B2 (hu) |
| CA (1) | CA2074709A1 (hu) |
| CZ (1) | CZ281712B6 (hu) |
| DE (2) | DE4125116A1 (hu) |
| DK (1) | DK0525537T3 (hu) |
| ES (1) | ES2059181T3 (hu) |
| HU (1) | HU208632B (hu) |
| IE (1) | IE65109B1 (hu) |
| IL (1) | IL102648A (hu) |
| MX (1) | MX9204423A (hu) |
| NO (1) | NO300253B1 (hu) |
| RU (1) | RU2043102C1 (hu) |
| SK (1) | SK238692A3 (hu) |
| TW (1) | TW202388B (hu) |
| ZA (1) | ZA925686B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863360A (en) * | 1988-01-15 | 1989-09-05 | Rogers Industrial Products | Bag control mechanism for tire press |
-
1991
- 1991-07-30 DE DE4125116A patent/DE4125116A1/de not_active Withdrawn
-
1992
- 1992-07-07 TW TW081105356A patent/TW202388B/zh active
- 1992-07-15 NO NO922795A patent/NO300253B1/no unknown
- 1992-07-17 ES ES92112201T patent/ES2059181T3/es not_active Expired - Lifetime
- 1992-07-17 DE DE59200530T patent/DE59200530D1/de not_active Expired - Fee Related
- 1992-07-17 EP EP92112201A patent/EP0525537B1/de not_active Expired - Lifetime
- 1992-07-17 DK DK92112201.6T patent/DK0525537T3/da active
- 1992-07-17 AT AT92112201T patent/ATE111732T1/de not_active IP Right Cessation
- 1992-07-22 AU AU20484/92A patent/AU659177B2/en not_active Ceased
- 1992-07-27 CA CA002074709A patent/CA2074709A1/en not_active Abandoned
- 1992-07-27 IL IL102648A patent/IL102648A/xx not_active IP Right Cessation
- 1992-07-29 IE IE922467A patent/IE65109B1/en not_active IP Right Cessation
- 1992-07-29 KR KR1019920013561A patent/KR930001908A/ko not_active Application Discontinuation
- 1992-07-29 RU SU925052306A patent/RU2043102C1/ru active
- 1992-07-29 MX MX9204423A patent/MX9204423A/es not_active IP Right Cessation
- 1992-07-29 ZA ZA925686A patent/ZA925686B/xx unknown
- 1992-07-29 JP JP22094392A patent/JP3381198B2/ja not_active Expired - Fee Related
- 1992-07-30 SK SK2386-92A patent/SK238692A3/sk unknown
- 1992-07-30 HU HU9202484A patent/HU208632B/hu not_active IP Right Cessation
- 1992-07-30 CZ CS922386A patent/CZ281712B6/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ238692A3 (en) | 1994-01-19 |
| DK0525537T3 (da) | 1995-02-20 |
| HUT63330A (en) | 1993-08-30 |
| NO922795L (no) | 1993-02-01 |
| ATE111732T1 (de) | 1994-10-15 |
| KR930001908A (ko) | 1993-02-22 |
| DE59200530D1 (de) | 1994-10-27 |
| IE65109B1 (en) | 1995-10-04 |
| IE922467A1 (en) | 1993-02-10 |
| NO300253B1 (no) | 1997-05-05 |
| NO922795D0 (no) | 1992-07-15 |
| DE4125116A1 (de) | 1993-02-04 |
| HU9202484D0 (en) | 1992-10-28 |
| CA2074709A1 (en) | 1993-01-31 |
| RU2043102C1 (ru) | 1995-09-10 |
| IL102648A0 (en) | 1993-01-14 |
| ES2059181T3 (es) | 1994-11-01 |
| HU208632B (en) | 1993-12-28 |
| ZA925686B (en) | 1993-04-28 |
| EP0525537A1 (de) | 1993-02-03 |
| MX9204423A (es) | 1993-01-01 |
| CZ281712B6 (cs) | 1996-12-11 |
| AU2048492A (en) | 1993-02-04 |
| EP0525537B1 (de) | 1994-09-21 |
| TW202388B (hu) | 1993-03-21 |
| JP3381198B2 (ja) | 2003-02-24 |
| JPH06157314A (ja) | 1994-06-03 |
| IL102648A (en) | 1997-03-18 |
| AU659177B2 (en) | 1995-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4767982B2 (ja) | 末梢または中枢神経障害およびサイトカイン過剰産生の治療のためのｋ−２５２ａ誘導体の使用 | |
| WO1998008546A8 (en) | Therapeutic combinations of rar antagonists and rxr agonists and use thereof | |
| CA2070685C (en) | Method for treating painful, inflammatory or allergic disorders | |
| AU2002340971B2 (en) | Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders | |
| Czuczwar et al. | Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice | |
| AU1046302A (en) | Transdermal therapeutic system | |
| DE69114470T2 (de) | Komposition für die behandlung von augenschmerzen. | |
| WO2004010946A3 (en) | Therapeutic treatment for the metabolic syndrome and type 2 diabetes | |
| Kaya et al. | Effects of ibuprofen and low-level laser therapy on orthodontic pain by means of the analysis of interleukin 1-beta and substance P levels in the gingival crevicular fluid. | |
| Knapp et al. | The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration | |
| EP0804185B1 (en) | Arsenic medicaments for the treatment of chronic fatigue syndrome | |
| US5006510A (en) | Method for relieving chronic pain with a somatostatin analog composition | |
| SK238692A3 (en) | Use 1,4-dihydropyridines for preparation of medicaments for diabetes treating | |
| EP0214933A2 (de) | Kombinationspräparate zur Behandlung von Malaria | |
| MX9805317A (es) | Agente para la profilaxis y el tratamiento de complicaciones diabeticas. | |
| BR0317289A (pt) | Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico | |
| KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
| Gispen et al. | The Ca2+ antagonist nimodipine counteracts the onset of an experimental neuropathy in streptozotocin induced, diabetic rats | |
| US5438144A (en) | Use of 1,4-dihydropyridines in diabetes | |
| DE3719367A1 (de) | Verwendung von den stoffwechsel und/oder die struktureigenschaften von kollagen beeinflussenden wirksubstanzen in der kieferorthopaedie | |
| EP1632235A3 (en) | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders | |
| EP0304897A2 (de) | Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen | |
| WO2003086417B1 (de) | Verwendung von pyrimidinnukleotiden zur behandlung von schädigungen des peripheren nervensystems | |
| RU2148995C1 (ru) | Способ стимуляции иммунобиологической резистентности | |
| DK601788A (da) | Anvendelse af antibiotikaene ll-e19020alfa og ll-e19020beta til behandling af visse fjerkraesygdomme |